Latest stories on SABS
SAB Biotherapeutics (SABS) and Breakthrough T1D Award Research Grant For SAB-142 Assessment
Yahoo Finance56 · neutralgeneral
SAB Biotherapeutics advances SAB-142 Type 1 diabetes trial
TipRanks63 · neutralproduct/pr
SAB Biotherapeutics, Inc. (SABSW) files 8-K
SEC 8-K50 · neutralgeneral
Breakthrough T1D Awards Grant to Support PRISE‑hATG Study of SAB‑142 in Stage 3 Type 1 Diabetes
Business Insider59 · neutralgeneral
Why Is H.C. Wainwright Bullish On SAB Biotherapeutics (SABS) With $10 Price Target?
Yahoo Top63 · neutralanalyst
Barclays Assigns Overweight Rating to SAB Biotherapeutics Inc. (SABS)
Yahoo Finance61 · neutralanalyst
SAB Biotherapeutics, Inc. (SABS) Presents at FOCIS 2026 Annual Meeting - Slideshow
Seeking Alpha50 · neutralgeneral